KEY TAKEAWAYS:

Pfizer agrees to lower drug prices under Trump deal

Medicaid to receive most-favored-nation pricing on new drugs

Company pledges $70B investment in U.S. manufacturing

Trump says more drugmaker deals will be announced soon

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals will be struck with other drugmakers facing a threat of tariffs .

The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. It also came as Washington faced a federal government shutdown at midnight amid a standoff between Democrats and Republicans over health care and its costs.

See Full Page